Secondary donor-derived humanized CD19-modified CAR-T cells induce remission in relapsed/refractory mixed phenotype acute leukemia after allogeneic hematopoietic stem cell transplantation: a case report

被引：0
|
作者：
Meng-Yun Li
Zhi-Hong Lin
Ming-Ming Hu
Li-Qing Kang
Xiao-xia Wu
Qi-wei Chen
Xin Kong
Jian Zhang
Hui-Ying Qiu
De-Pei Wu
机构：
[1] The First Affiliated Hospital of Soochow University,Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Collaborative Innovation Center of Hematology
[2] Institute of Blood and Marrow Transplantation,Institute of Biomedical Engineering and Technology, Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development
[3] Soochow University,undefined
[4] Suzhou Yongding Hospital,undefined
[5] School of Chemistry and Molecular Engineering,undefined
[6] East China Normal University,undefined
[7] Shanghai Unicar-Therapy Bio-medicine Technology Co.,undefined
[8] Ltd,undefined
来源：
Biomarker Research | / 8卷
关键词：
CD19; Chimeric antigen receptor T cells; Donor-derived; Humanized; Mixed phenotype acute leukemia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Secondary donor-derived humanized CD19-modified CAR-T cells induce remission in relapsed/refractory mixed phenotype acute leukemia after allogeneic hematopoietic stem cell transplantation: a case report
    Li, Meng-Yun
    Lin, Zhi-Hong
    Hu, Ming-Ming
    Kang, Li-Qing
    Wu, Xiao-xia
    Chen, Qi-wei
    Kong, Xin
    Zhang, Jian
    Qiu, Hui-Ying
    Wu, De-Pei
    BIOMARKER RESEARCH, 2020, 8 (01)
  • [2] Allogeneic donor-derived CD19 CAR-T therapy of relapsed B-cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation
    马润芝
    China Medical Abstracts(Internal Medicine), 2021, 38 (04) : 228 - 229
  • [3] DONOR-DERIVED CAR-T CELLS FOR THE TREATMENT OF RELAPSED ACUTE B-LYMPHOBLASTIC LEUKEMIA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Deng, Lei
    Yu, Xiaolin
    Song, Xiaocheng
    Guan, Rui
    Shao, Yan
    Li, Wenjun
    Zhou, Fang
    BONE MARROW TRANSPLANTATION, 2024, 59 : 47 - 48
  • [4] Allogeneic Donor-Derived Myeloid Antigen Directed CAR-T Cells - for Relapsed/Refractory Acute Myeloid Leukemia in Children after Allogeneic Hematopoietic Stem Cell Transplantation: Report of Three Cases
    Shelikhova, Larisa
    Rakhteenko, Arina
    Molostova, Olga
    Kurnikova, Elena
    Ukrainskaya, V
    Muzalevsky, Yakov
    Pershin, Dmitry
    Popov, Alexander
    Kulakovskaya, Elena
    Baidildina, Dina
    Stepanov, Alexey
    Osipova, Elena
    Novichkova, Galina
    Maschan, Alexey
    Maschan, Michael
    BLOOD, 2022, 140 : 4600 - 4601
  • [5] DONOR-DERIVED LYMPHOID ANTIGEN-DIRECTED CAR-T CELLS FOR RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA IN CHILDREN AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: REPORT OF 17 CASES
    Molostova, Olga
    Shelikhova, Larisa
    Khismatullina, Rimma
    Lyudovskikh, Evelina
    Abugova, Yuliya
    Pershin, Dmitriy
    Klimentova, Maria
    Shipitsina, Irina
    Malakhova, Ekaterina
    Fadeeva, Maria
    Kulakovskaya, Alena
    Khachatryan, Lili
    Vedmedskaya, Viktoria
    Novichkova, Galina
    Maschan, Alexei
    Maschan, Michael
    BONE MARROW TRANSPLANTATION, 2024, 59 : 223 - 223
  • [6] Role of Donor-Derived CD19.CAR-T Cells in Treating Patients That Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation
    Zhang, Cheng
    Gao, Lei
    Liu, Yao
    Gao, Li
    Kong, Pei-Yan
    Liu, Jun
    Huang, Ruihao
    Ma, Ying-Ying
    Zeng, Defu
    Xiong, Qing-Hui
    Mei, Wei-Ling
    Liu, Jia
    Jiang, Peng-Fei
    Ye, Xun
    Han, De-Ping
    Cao, Wei
    Zhang, Xi
    BLOOD, 2019, 134
  • [7] CAR-T cells and allogeneic hematopoietic stem cell transplantation for relapsed/refractory B-cell acute lymphoblastic leukemia
    Liu, Jun
    Zhang, Xi
    Zhong, Jiang F.
    Zhang, Cheng
    IMMUNOTHERAPY, 2017, 9 (13) : 1115 - 1125
  • [8] Efficacy and risk of donor-derived CAR-T treatment of relapsed B-cell acute lymphoblastic leukemia after hematopoietic stem cell transplantation
    Deng, Lei
    Yu, Xiaolin
    Song, Xiaocheng
    Guan, Rui
    Li, Wenjun
    Hou, Yixi
    Shao, Yan
    Zhao, Yuerong
    Wang, Jing
    Liu, Yue
    Xiao, Qianqian
    Xin, Bo
    Zhou, Fang
    CYTOTHERAPY, 2024, 26 (11) : 1301 - 1307
  • [9] Allogeneic Donor-Derived Anti-CD19 CAR T Cell Is a Promising Therapy for Relapsed/Refractory B-ALL After Allogeneic Hematopoietic Stem-Cell Transplantation
    Hua, Jingsheng
    Zhang, Jian
    Wu, Xiaoxia
    Zhou, Lili
    Bao, Xiebing
    Han, Yue
    Miao, Miao
    Li, Caixia
    Fu, Zhengzheng
    Wu, Depei
    Qian, Weiqing
    Qiu, Huiying
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (09): : 610 - 616
  • [10] Donor-derived stem cell infusion for sustained pancytopenia after CD19 CAR-T therapy for relapsed patients post allogeneic stem cell transplantation
    Li, Yingying
    Li, Yixue
    Zhang, Mingming
    Zhao, Houli
    Zhu, Miaoyong
    Huang, He
    Hu, Yongxian
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 112 (01) : 94 - 101
12345